Olivier Henry, Ph.D. - Publications

Affiliations: 
2004 Ecole Polytechnique, Montreal (Canada) 
Area:
Chemical Engineering, Microbiology Biology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Silva CAT, Kamen AA, Henry O. Intensified Influenza Virus Production in Suspension HEK293SF Cell Cultures Operated in Fed-Batch or Perfusion with Continuous Harvest. Vaccines. 11. PMID 38140223 DOI: 10.3390/vaccines11121819  0.432
2020 Henry O, Karengera E, Cambay F, De Crescenzo G. Surface Plasmon Resonance-Based Method for Rapid Product Sialylation Assessment in Cell Culture. Methods in Molecular Biology (Clifton, N.J.). 2095: 285-293. PMID 31858474 DOI: 10.1007/978-1-0716-0191-4_16  0.46
2019 Venereo-Sánchez A, Fulton K, Koczka K, Twine S, Chahal P, Ansorge S, Gilbert R, Henry O, Kamen A. Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF. Vaccine. PMID 31358407 DOI: 10.1016/J.Vaccine.2019.07.057  0.385
2019 Mellahi K, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O. Assessment of Fed-batch Cultivation Strategies for an Inducible CHO Cell Line. Journal of Biotechnology. PMID 30959136 DOI: 10.1016/J.Jbiotec.2019.04.005  0.649
2019 Mellahi K, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O. Process intensification for the production of rituximab by an inducible CHO cell line. Bioprocess and Biosystems Engineering. PMID 30673843 DOI: 10.1007/S00449-019-02075-Z  0.66
2018 Mellahi K, Cambay F, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O. Process Development for an Inducible Rituximab-Expressing CHO Cell Line. Biotechnology Progress. PMID 30414355 DOI: 10.1002/Btpr.2742  0.666
2018 Karengera E, Robotham A, Kelly J, Durocher Y, De Crescenzo G, Henry O. Concomitant reduction of lactate and ammonia accumulation in fed-batch cultures: Impact on glycoprotein production and quality. Biotechnology Progress. PMID 29314777 DOI: 10.1002/Btpr.2607  0.54
2017 Karengera E, Durocher Y, De Crescenzo G, Henry O. Combining metabolic and process engineering strategies to improve recombinant glycoprotein production and quality. Applied Microbiology and Biotechnology. PMID 28924963 DOI: 10.1007/S00253-017-8513-0  0.57
2017 Venereo-Sanchez A, Simoneau M, Lanthier S, Chahal P, Bourget L, Ansorge S, Gilbert R, Henry O, Kamen A. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line. Vaccine. PMID 28648546 DOI: 10.1016/J.Vaccine.2017.06.024  0.476
2017 Riahi N, Liberelle B, Henry O, De Crescenzo G. Impact of RGD amount in dextran-based hydrogels for cell delivery. Carbohydrate Polymers. 161: 219-227. PMID 28189232 DOI: 10.1016/J.Carbpol.2017.01.002  0.316
2016 Karengera E, Robotham A, Kelly J, Durocher Y, De Crescenzo G, Henry O. Altering the central carbon metabolism of HEK293 cells: Impact on recombinant glycoprotein quality. Journal of Biotechnology. PMID 27940295 DOI: 10.1016/J.Jbiotec.2016.12.003  0.54
2016 Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate. Vaccine. PMID 27155499 DOI: 10.1016/J.Vaccine.2016.04.089  0.363
2016 Toussaint C, Henry O, Durocher Y. Metabolic engineering of CHO cells to alter lactate metabolism during fed-batch cultures. Journal of Biotechnology. 217: 122-31. PMID 26603123 DOI: 10.1016/J.Jbiotec.2015.11.010  0.57
2015 Thompson CM, Petiot E, Mullick A, Aucoin MG, Henry O, Kamen AA. Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems. Bmc Biotechnology. 15: 31. PMID 25981500 DOI: 10.1186/S12896-015-0152-X  0.322
2014 Ghorbaniaghdam A, Henry O, Jolicoeur M. An in-silico study of the regulation of CHO cells glycolysis. Journal of Theoretical Biology. 357: 112-22. PMID 24801859 DOI: 10.1016/J.Jtbi.2014.04.035  0.422
2014 Sheikholeslami Z, Jolicoeur M, Henry O. Elucidating the effects of postinduction glutamine feeding on the growth and productivity of CHO cells. Biotechnology Progress. 30: 535-46. PMID 24692260 DOI: 10.1002/Btpr.1907  0.582
2014 Ghorbaniaghdam A, Chen J, Henry O, Jolicoeur M. Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform. Plos One. 9: e90832. PMID 24632968 DOI: 10.1371/Journal.Pone.0090832  0.51
2014 Vallée C, Durocher Y, Henry O. Exploiting the metabolism of PYC expressing HEK293 cells in fed-batch cultures. Journal of Biotechnology. 169: 63-70. PMID 24246270 DOI: 10.1016/J.Jbiotec.2013.11.002  0.562
2013 Thompson CM, Petiot E, Lennaertz A, Henry O, Kamen AA. Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches. Virology Journal. 10: 141. PMID 23642219 DOI: 10.1186/1743-422X-10-141  0.338
2013 Sheikholeslami Z, Jolicoeur M, Henry O. Probing the metabolism of an inducible mammalian expression system using extracellular isotopomer analysis. Journal of Biotechnology. 164: 469-78. PMID 23403402 DOI: 10.1016/J.Jbiotec.2013.01.025  0.516
2013 Ghorbaniaghdam A, Henry O, Jolicoeur M. A kinetic-metabolic model based on cell energetic state: study of CHO cell behavior under Na-butyrate stimulation. Bioprocess and Biosystems Engineering. 36: 469-87. PMID 22976819 DOI: 10.1007/S00449-012-0804-3  0.437
2013 Sheikholeslami Z, Jolicoeur M, Henry O. The impact of the timing of induction on the metabolism and productivity of CHO cells in culture Biochemical Engineering Journal. 79: 162-171. DOI: 10.1016/J.Bej.2013.07.015  0.605
2011 Henry O, Durocher Y. Enhanced glycoprotein production in HEK-293 cells expressing pyruvate carboxylase. Metabolic Engineering. 13: 499-507. PMID 21624497 DOI: 10.1016/J.Ymben.2011.05.004  0.573
2011 Henry O, Jolicoeur M, Kamen A. Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess and Biosystems Engineering. 34: 263-73. PMID 20848294 DOI: 10.1007/S00449-010-0468-9  0.515
2011 Ansorge S, Lanthier S, Transfiguracion J, Henry O, Kamen A. Monitoring lentiviral vector production kinetics using online permittivity measurements Biochemical Engineering Journal. 54: 16-25. DOI: 10.1016/J.Bej.2011.01.002  0.475
2010 Le Ru A, Jacob D, Transfiguracion J, Ansorge S, Henry O, Kamen AA. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine. 28: 3661-71. PMID 20347632 DOI: 10.1016/J.Vaccine.2010.03.029  0.428
2010 Henry O, Durocher Y. Engineering of the human cell line HEK-293 to enhance recombinant protein production Ifac Proceedings Volumes (Ifac-Papersonline). 11: 473-478. DOI: 10.3182/20100707-3-Be-2012.0110  0.538
2010 Ghorbaniaghdam A, Henry O, Jolicoeur M. A kinetic modelling approach to study the role of energy regulatory pathways in CHO cells Ifac Proceedings Volumes (Ifac-Papersonline). 11: 479-484. DOI: 10.3182/20100707-3-Be-2012.0109  0.45
2010 Ansorge S, Henry O, Kamen A. Recent progress in lentiviral vector mass production Biochemical Engineering Journal. 48: 362-377. DOI: 10.1016/J.Bej.2009.10.017  0.447
2009 Ansorge S, Lanthier S, Transfiguracion J, Durocher Y, Henry O, Kamen A. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. The Journal of Gene Medicine. 11: 868-76. PMID 19618482 DOI: 10.1002/Jgm.1370  0.48
2008 Henry O, Kwok E, Piret JM. Simpler noninstrumented batch and semicontinuous cultures provide mammalian cell kinetic data comparable to continuous and perfusion cultures. Biotechnology Progress. 24: 921-31. PMID 19194901 DOI: 10.1002/Btpr.17  0.431
2007 Henry O, Ansorge S, Aucoin M, Voyer R, Kamen A. On-Line Monitoring Of Cell Size Distribution In Mammalian Cell Culture Processes Ifac Proceedings Volumes. 40: 277-282. DOI: 10.3182/20070604-3-Mx-2914.00048  0.435
2007 Henry O, Kamen A, Perrier M. Monitoring the physiological state of mammalian cell perfusion processes by on-line estimation of intracellular fluxes Journal of Process Control. 17: 241-251. DOI: 10.3182/20060402-4-Br-2902.00047  0.6
2007 Henry O, Ansorge S, Aucoin M, Voyer R, Kamen A. On-line monitoring of cell size distribution in mammalian cell culture processes Ifac Proceedings Volumes (Ifac-Papersonline). 10: 277-282.  0.335
2005 Henry O, Perrier M, Kamen A. Metabolic flux analysis of HEK-293 cells in perfusion cultures for the production of adenoviral vectors. Metabolic Engineering. 7: 467-76. PMID 16198135 DOI: 10.1016/J.Ymben.2005.08.002  0.667
2004 Henry O, Dormond E, Perrier M, Kamen A. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnology and Bioengineering. 86: 765-74. PMID 15162452 DOI: 10.1002/Bit.20074  0.67
2004 Kamen A, Henry O. Development and optimization of an adenovirus production process. The Journal of Gene Medicine. 6: S184-92. PMID 14978761 DOI: 10.1002/Jgm.503  0.5
2004 Henry O, Perrier M, Kamen A. On-Line Monitoring of Adenovirus Production in Perfusion Cultures Ifac Proceedings Volumes. 37: 381-386. DOI: 10.1016/S1474-6670(17)32611-3  0.644
2001 Nadeau I, Jacob D, Henry O, Perrier M, Kamen A. Enhanced Adenovirus Production by 293 Cells Using a Low-Protein Medium: A Metabolic Flux Analysis Ifac Proceedings Volumes. 34: 361-366. DOI: 10.1016/S1474-6670(17)34246-5  0.696
Show low-probability matches.